BIO-Europe® 2016- Value and the pricing of innovation

November 7, 2016
Balancing the cost of innovation and ensuring access to high-quality, effective medical treatment continues to be a challenge for all modern healthcare systems. Significant shifts in global and local market dynamics, policy and politics are prompting a discussion about other dimensions of value, be they economic, social, or scientific. How can biotech innovators best demonstrate the value of their therapies so that outcomes are measurable and relevant to all stakeholders?
Previous Video
BEU16 Big pharma's approach to digital medicine
BEU16 Big pharma's approach to digital medicine

Next Video
BIO-Europe® 2016: Welcome and Opening Plenary Discussion
BIO-Europe® 2016: Welcome and Opening Plenary Discussion

Balancing the cost of innovation and ensuring access to high-quality, effective medical treatment continues...